Category: Medicines

This is the default blog subtitle.

Are pharma companies prepared for Brexit?

Are pharma companies prepared for Brexit?

The European Medicines Agency (EMA) and the European Commission are currently providing guidance to help pharmaceutical companies responsible for medicines to be prepared for the UK withdrawal from the EUwhich will become a third country as of 30 March 2019. The objective is to ensure that companies are ready to take the necessary steps to enable undisrupted supply of their medicines […]

Read More

EMA prepares for Brexit

EMA prepares for Brexit

Business continuity plan aims to preserve Agency’s ability to protect public and animal health The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. The business continuity plan is a […]

Read More